Related Experiment Video
Updated: Jan 13, 2026
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Effectiveness of sodium thiosulfate in acquired reactive perforating collagenosis: A case report
Bocheng Zhu1, Keqing Zhu1, Liyu Pan1
1Department of Nephrology, No. 903 Hospital of PLA Joint Logistic Support Force, Hangzhou, China.
Rationale:
Acquired reactive perforating collagenosis (ARPC) is a challenging dermatological complication in end-stage renal disease (ESRD) patients on hemodialysis, characterized by transepidermal elimination of degenerated collagen and intense pruritus. Treatment options are limited and lack consensus. Based on its established safety profile in ESRD and pathophysiological rationale, we evaluated sodium thiosulfate (STS) as a novel therapeutic option for ARPC.
Patient Concerns:
A 70-year-old male with ESRD on hemodialysis and type 2 diabetes presented with widespread pruritic papules consistent with ARPC.
Diagnoses:
The diagnosis of ARPC was confirmed histologically by Masson trichrome staining.
Interventions:
After unsatisfactory responses to topical steroids and antihistamines, intravenous STS (3.2 g after hemodialysis, 3 times weekly) was initiated.
Outcomes:
The patient showed marked clinical improvement in pruritus and skin lesions within 1 month, with a corresponding decrease in eosinophil count and IgE levels. No adverse effects, such as metabolic acidosis or gastrointestinal symptoms, were observed.
Lessons:
STS may be an effective and well-tolerated treatment for ARPC in hemodialysis patients. The observed immunomodulatory changes, though possibly related to symptom resolution, support further investigation into its mechanism of action.
